StockWatch
·

BLISS GVS PHARMA LTD. Q3 FY25 Results

BLISSGVSQ3 FY25 Results
Filing
MetricValue ( Cr)vs Q2 FY25
Revenue210.423.3%
Total Income225.681.3%
Expenditure189.261.2%
PBT36.422.0%
Net Profit25.800.4%
OPM5.95%3.17pp
NPM11.43%0.11pp
EPS2.271.7%
View full financials

Informational and educational content only. Not investment advice.